Discover open access scientific publications

Search, annotate, share and cite publications

Publications in Pharmacology

High Incidence of Autoimmune Gastritis in Patients Misdiagnosed With Two or More Failures of H. Pylori Eradication

Alimentary Pharmacology and Therapeutics

English

Lenalidomide as Second-Line Therapy for Advanced Hepatocellular Carcinoma: Exploration of Biomarkers for Treatment Efficacy

Alimentary Pharmacology and Therapeutics

English

Editorial: Not Yet Time for Universal Susceptibility-Guided First-Line Helicobacter Pylori Treatment

Alimentary Pharmacology and Therapeutics

English

Editorial: De Novo Inflammatory Bowel Disease Following Bariatric Surgery-Potential Implications for Research and Clinical Practice. Authors’ Reply

Alimentary Pharmacology and Therapeutics

English

Letter: Chronic Kidney Disease Risk in Patients With Chronic Hepatitis B-Authors’ Reply

Alimentary Pharmacology and Therapeutics

English

Letter: Can Addition of an Immunomodulator Really Reverse Antibody Formation and Loss of Response in Patients Treated With Adalimumab?

Alimentary Pharmacology and Therapeutics

English

Letter: Comparative Diagnostic Accuracy of Magnetic Resonance Elastography vs. Eight Clinical Prediction Rules for Non-Invasive Diagnosis of Advanced Fibrosis in Biopsy-Proven NAFLD - Author's Reply

Alimentary Pharmacology and Therapeutics

English

Editorial: Retreatment of DAA-failures-no Problem at All?

Alimentary Pharmacology and Therapeutics

English

Editorial: First Among Equals-Not for Either Infliximab or Adalimumab in Crohn's Disease-Yet

Alimentary Pharmacology and Therapeutics

English

Editorial: Which Iron Preparation for Patients With IBD? Authors’ Reply

Alimentary Pharmacology and Therapeutics

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications in Pharmacology

High Incidence of Autoimmune Gastritis in Patients Misdiagnosed With Two or More Failures of H. Pylori Eradication

Lenalidomide as Second-Line Therapy for Advanced Hepatocellular Carcinoma: Exploration of Biomarkers for Treatment Efficacy

Editorial: Not Yet Time for Universal Susceptibility-Guided First-Line Helicobacter Pylori Treatment

Editorial: De Novo Inflammatory Bowel Disease Following Bariatric Surgery-Potential Implications for Research and Clinical Practice. Authors’ Reply

Letter: Chronic Kidney Disease Risk in Patients With Chronic Hepatitis B-Authors’ Reply

Letter: Can Addition of an Immunomodulator Really Reverse Antibody Formation and Loss of Response in Patients Treated With Adalimumab?

Letter: Comparative Diagnostic Accuracy of Magnetic Resonance Elastography vs. Eight Clinical Prediction Rules for Non-Invasive Diagnosis of Advanced Fibrosis in Biopsy-Proven NAFLD - Author's Reply

Editorial: Retreatment of DAA-failures-no Problem at All?

Editorial: First Among Equals-Not for Either Infliximab or Adalimumab in Crohn's Disease-Yet

Editorial: Which Iron Preparation for Patients With IBD? Authors’ Reply